Feasibility of a quantitative polymerase chain reaction assay for diagnosing pneumococcal pneumonia using...

Area of Science:

• Microbiology
• Molecular Diagnostics
• Infectious Diseases

Background:

• Streptococcus pneumoniae is a primary cause of community-acquired pneumonia (CAP).
• Current diagnostic methods detect S. pneumoniae in less than 30% of CAP cases, necessitating improved diagnostic tools.
• Quantitative PCR targeting the autolysin (lytA) gene presents a promising approach to increase detection rates.

Purpose of the Study:

• To validate a quantitative PCR assay targeting the lytA gene for Streptococcus pneumoniae detection.
• To assess the assay's performance in vitro using various bacterial strains and in vivo using clinical samples.
• To determine the assay's diagnostic accuracy, including sensitivity, specificity, and lower limit of detection.

Main Methods:

• Validation of the quantitative PCR (qPCR) assay for lytA gene detection.
• In vitro testing included intra- and inter-run variability, specificity, sensitivity, and lower limit of detection.
• In vivo validation involved a pilot study using oropharyngeal swabs from patients with confirmed pneumococcal pneumonia and pneumonia of other etiologies.

Main Results:

• The qPCR assay demonstrated low intra- and inter-run variability (SDs 0.08-0.96 CT).
• In vitro, the assay achieved 100% sensitivity and specificity with a lower limit of detection of 1-10 DNA copies/reaction.
• In the patient pilot study, a cut-off of 6,000 copies/mL yielded 57.1% sensitivity and 85.7% specificity for diagnosing pneumococcal pneumonia.

Conclusions:

• A quantitative PCR assay targeting the lytA gene was successfully developed and validated.
• The assay exhibits excellent in vitro performance characteristics for detecting Streptococcus pneumoniae.
• This qPCR method holds potential for improving the diagnosis of pneumococcal pneumonia, especially in cases missed by standard methods.